Dexmedetomidine-associated diabetes insipidus during skull base surgery in a pediatric patient

Emily G Reynolds1, Lauren M Van Decar2,3, Emily E Sharpe4

  • 1Mayo Clinic School of Medicine, Scottsdale, Arizona, USA.

Paediatric Anaesthesia
|October 29, 2022
PubMed

Insights

Dexmedetomidine may cause transient diabetes insipidus in pediatric patients undergoing surgery. This condition, marked by excessive urination, resolved after discontinuing the anesthetic, highlighting a rare intraoperative complication.

Area of Science:

  • Anesthesiology
  • Pediatric Endocrinology
  • Neurosurgery

Background:

  • Diabetes insipidus (DI) is a condition of water imbalance causing polyuria.
  • Intraoperative anesthetics are a known cause of DI in adults, but rarely in pediatrics.
  • Juvenile nasopharyngeal angiofibromas are benign tumors requiring surgical intervention.

Observation:

  • A 16-year-old male presented with polyuria during surgery for a recurrent nasopharyngeal angiofibroma.
  • The patient received dexmedetomidine, an anesthetic agent.
  • Intraoperative polyuria suggested a diagnosis of diabetes insipidus.

Findings:

  • Discontinuation of dexmedetomidine led to a significant decrease in urine output.
  • The patient's water balance normalized within 24 hours post-administration.
  • This case suggests dexmedetomidine as a potential cause of transient DI in pediatric surgical patients.

Implications:

  • Highlights a rare pediatric complication of dexmedetomidine use.
  • Suggests monitoring for DI in pediatric patients receiving dexmedetomidine during surgery.
  • Informs anesthetic management for pediatric patients with nasopharyngeal angiofibromas.